Coupang Inc. (NYSE: CPNG): Deutsche Bank downgraded the shares to Hold from Buy and has a $20 target price. The consensus target is $21.79. The stock closed 8% higher on Wednesday at $19.30 after earnings beat estimates.
Datadog Inc. (NASDAQ: DDOG): Stifel’s downgrade to Hold from Buy included a target price cut to $90 from $115. The consensus target is $106.32. Wednesday’s closing share price was $86.76.
Dish Network Corp. (NASDAQ: DISH): Barclays upgraded the stock to Equal Weight from Underweight. The analyst also raised the $5 target price to $10, though the consensus target is $15.98 for now. The stock closed on Wednesday at $8.27.
DraftKings Inc. (NASDAQ: DKNG): J.P. Morgan upgraded the shares to Neutral from Underweight and has a $26 target price. The consensus target is $35.29. The shares closed on Wednesday at $28.26, down almost 11% for the day due to the Disney/Penn Gaming deal.
Eli Lilly and Co. (NYSE: LLY): As Jefferies upgraded the stock to Buy from Hold, its $408 target price jumped to $615. The consensus target is $495.49. Wednesday’s close was at $526.23.
GlobalFoundries Inc. (NASDAQ: GFS): Morgan Stanley reiterated an Overweight rating but trimmed its $80 target price to $73. Deutsche Bank reiterated a Buy rating and lowered its target to $65 from $70. The consensus target is $72.13, and shares closed on Wednesday at $59.21.
International Flavors & Fragrances Inc. (NYSE: IFF): When Goldman Sachs downgraded the stock to Neutral from Buy, the $120 target price dropped to $78. The consensus target is $98.16 for now. Wednesday’s close was at $63.78. The company cut full-year sales guidance earlier this week.
LivePerson Inc. (NASDAQ: LPSN): Craig Hallum upgraded the stock to Buy from Hold. Its $7 target price is well above the $4.81 consensus target. The stock closed almost 20% higher on Wednesday at $4.75, after the upgrade and the company posted earnings and revenue that surpassed estimates.
Mirati Therapeutics Inc. (NASDAQ: MRTX): The B. Riley Securities upgrade was from Neutral to Buy with a $45 target price. The consensus target is $57.53 for now. Wednesday’s $37.00 close was up 33% for the day on positive clinical data, the CEO’s departure and the upgrade.
Novavax Inc. (NASDAQ: NVAX): The Neutral rating at B. Riley Securities is now at Buy, but the $15 target price is less than the $21.40 consensus target. Wednesday’s close was at $7.12.
Nvidia Corp. (NASDAQ: NVDA): Stifel reiterated its Hold rating. The analyst also boosted its $370 target price to $440, though the consensus target is $454.40. The stock closed almost 5% lower on Wednesday at $425.54.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
